About ABHI



The group works with a broad range of stakeholders to raise the profile of the sector, identify barriers to patients accessing appropriate treatments and provide tangible solutions. It has two key working groups, one focused on Vascular technologies and one on Heart Valve solutions.

  • Chair (Vascular) - Declan Dunphy, Cook Medical
  • Vice Chairs (Vascular) - Andy Shepherd, Philips & Rachel Duggan, BTG
  • Chair (Heart Valve) - Ameer Ally, Edwards Lifesciecnes 
  • Vice Chair (Heart Valve) - Jane Nixon, Medtronic
  • In 2019, the British Society of Interventional Radiology (BSIR) delivered a compelling and well-attended conference following continued engagement with the Vascular Group.
  • With ABHI member support, the Vascular Society has begun the first pilot of a device-specific registry for abdominal aortic aneurysm (AAA) procedures.
  • Members co-ordinated a robust response to the AAA NICE Consultation, delivering broad stakeholder agreement and continued insight sharing.
  • Develop a broad member coalition raising the profile of cardiovascular solutions. In 2020, the group will look to identify specific solutions that will support the recommendations of the NHS Long Term plan.
  • To partner with relevant stakeholders to identify and develop registries that meet all stakeholder requirements. Development is underway with the National Vascular Registry and discussions are underway with the National Institute for Cardiovascular Outcomes Research registry.
  • To co-ordinate a clear and impactful response to relevant NICE guidance such as that focused on AAA and transcatheter aortic valve implantation (TAVI).
Useful Resources 
  • Click here to view the latest updates, minutes and future meeting dates for the group.
The UK's Cardiovascular Industry
  • 937m Turnover
  • 3,142 Staff
  • 66 Companies

Source: Bioscience and health technology database: annual report 2017


"Collecting data on the long-term performance of implantable medical devices is vital for patient safety. We have been working closely and collaboratively with the ABHI for two years, and specifically the manufacturers of devices used to treat abdominal aortic aneurysms to develop the National Vascular Registry to capture device-specific information at the time of implantation. Furthermore, we have designed the registry to collect and report on long-term device-specific outcomes. ABHI has been engaged, enthusiastic and driving for the same mutually agreed goals. It has been a pleasure working with an overarching body that represents the HealthTech industry and I look forward to maintaining this relationship to develop device capture for all patients with vascular disease”
Jon Boyle, Clinical Lead, National Vascular Registry